Unknown

Dataset Information

0

Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors.

ABSTRACT:

SUBMITTER: Prabakaran P 

PROVIDER: S-EPMC7111665 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown HIV entry and envelope glycoprotein-mediated fusion.
| S-EPMC3510787 | biostudies-literature
Unknown Naturally occurring variability in the envelope glycoprotein of HIV-1 and development of cell entry inhibitors.
| S-EPMC2840190 | biostudies-literature
Unknown A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry.
| S-EPMC4231716 | biostudies-literature
Unknown The HIV-1 envelope glycoprotein structure: nailing down a moving target.
| S-EPMC5300090 | biostudies-literature
Unknown Envelope-Specific Recognition Patterns of HIV Vaccine-Induced IgG Antibodies Are Linked to Immunogen Structure and Sequence.
| S-EPMC6492543 | biostudies-literature
Unknown N-Substituted Pyrrole Derivative 12m Inhibits HIV-1 Entry by Targeting Gp41 of HIV-1 Envelope Glycoprotein.
| S-EPMC6688628 | biostudies-literature
Unknown Mutations of Glu560 within HIV-1 Envelope Glycoprotein N-terminal heptad repeat region contribute to resistance to peptide inhibitors of virus entry.
| S-EPMC6889725 | biostudies-literature
Unknown HIV-1 envelope glycoprotein structure.
| S-EPMC3676719 | biostudies-literature
Unknown HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: implications for therapy and vaccine development.
| S-EPMC2490604 | biostudies-literature
Unknown Characterization of HCV genotype 5a envelope proteins: implications for vaccine development and therapeutic entry target.
| S-EPMC4286708 | biostudies-literature